Aluminium Sulfate CAS: 7784-31-8
Related Insights
The 1,550-Vessel Backlog and the Convoy Exit Queue: How Long Will It Take to Clear?
Although vessel movements through the Strait of Hormuz are increasing, the shipping backlog accumulated during the crisis remains substantial. Understanding convoy throughput and queue management provides buyers with a more realistic timeline for delayed chemical cargo arrivals during H2 2026.
Methanol: Ar-Razi's Suspended Exports and the Japanese JV's Q3 Supply Gap
The suspension of methanol exports from Ar-Razi Saudi Methanol, one of the world’s largest methanol producers and a critical Mitsubishi Gas Chemical joint venture, became one of the most important supply disruptions of the 2026 Hormuz crisis. This week may determine whether improving shipping conditions finally allow commercial supply recovery to begin.
Commodity Chemical Intelligence: The Kpler 34 Framework for Reading Physical Recovery vs Diplomatic Progress
The most important lesson from 124 days of the 2026 Hormuz crisis is that physical supply recovery and diplomatic progress move independently. For chemical procurement teams planning Q3 supply, vessel crossing data from Kpler now matters far more than political statements coming out of Doha negotiations.
The Nine Major Carriers' Hormuz Posture: Where Each Stands on July 1
The world's nine largest container shipping lines continue maintaining Cape of Good Hope routing as their operational standard entering H2 2026. For chemical buyers shipping under CIF and CFR contracts, understanding each carrier's operating posture is now a critical component of logistics and insurance planning.
Doha Talks Today: What US-Iran Negotiations Mean for Chemical Shipping Logistics and Global Procurement
Today's Doha talks could reshape chemical shipping logistics across the Gulf. With elevated maritime risk, delayed vessel movements and cautious carrier policies, procurement teams need to understand how today's diplomatic outcome could affect Q3 sourcing, freight costs and supply chain planning.
Pharmaceutical Supply Chain: H1 2026 Closing Risk Assessment
The first half of 2026 exposed major vulnerabilities in pharmaceutical supply chains. API concentration, shipping disruptions, and logistics risks are reshaping procurement strategies for H2 2026 and beyond.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.